News & Updates
The Glucagon-Like Peptide-1 Analogue Liraglutide Reduces Seizures Susceptibility, Cognition Dysfunction and Neuronal Apoptosis in a Mouse Model of Dravet Syndrome
Glucagon-like peptide-1 (GLP-1) is a hormone that is secreted from intestinal cells after food [...]
Fenfluramine acts as a positive modulator of sigma-1 receptors
In previous posts we have profiled fenfluramine as a recent promising add-on therapy for [...]
DSF Virtual Meet-Ups
Social distancing will mean we will be staying further apart from one another physically [...]
Welcome to Our New Board Members
Please join us in welcoming our two newest board members, Ashley Kerns and Dr. [...]
How can DSF help during these uncertain times?
This was a difficult blog post for me to sit down and write because [...]
Dravet Syndrome Foundation is a non-profit organization dedicated to aggressively raising research funds for Dravet syndrome, a rare and catastrophic form of epilepsy beginning in childhood, and related conditions. By offering research grants for syndrome-specific research with a novel approach, DSF can move researchers and the medical community forward to find better treatments and a cure while assisting afflicted individuals and their families.
Meet our superheroes who fight every day against Dravet!
Find out how to help us in the fight to cure Dravet syndrome
Upcoming Events
In the best interest of our medically fragile community due to the COVID-19 outbreak, all in-person events have been postponed through June 30, 2020. Please check back for updates to our events, and thank you for your continued support during this difficult time.